David A. Eagle, MD, is board certified in hematology-oncology and has a focus on gynecological malignancies. He has practiced for over two decades, previously practicing in Lake Norman, North Carolina. He is a past president of the Community Oncology Alliance and a member of the American Society of Clinical Oncology.

Dr. Eagle obtained his Doctor of Medicine from the University of Virginia School of Medicine. After earning his medical degree, he completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Florida. Dr. Eagle is particularly interested in healthcare policy to ensure patients have the best options available and benefit from the astonishing scientific advances in blood and cancer medicine.

Tammi Malave-Smalling, BS, CPC, is the practice administrator for Hematology Oncology Associates of Brooklyn, where she manages the group’s daily operations, contracts, financials, billing department, performance reporting, HIPAA, policies and procedures, and is also the practice representative. Tammi brings more than 15 years of practice management experience, and is an active member of the Medical Group Management Association, Hematology Oncology Managers of New York, American Academy of Professional Coders and the Community Oncology Alliance.

Jonas Congelli, RPh, has practiced as an oncology pharmacist since 1990. He currently serves as the chief of Pharmacy, Laboratory and Nutrition Services for Hematology Oncology Associates of Central New York (HOACNY), a large multispecialty community oncology practice with four practice locations, 17 physicians, and 300 employees. Pharmacy services at HOACNY, include: clinical drug information management by oncology pharmacists, infusion chemotherapy delivered from USP 797-certified clean rooms, oral chemotherapy and supportive medications dispensed from The Patient Rx Center, and clinical research support with protocols provided through the Alliance for Clinical Trials in Oncology.

Mr. Congelli graduated from Albany College of Pharmacy in 1989 and has a broad range of oncology experience including hospital inpatient, outpatient, and community oncology practice.

Una Hopkins, DNP, MSN, BSN, FNP-BC, NE-BC, FACCC, RN, is a registered nurse with more than 30 years of experience in oncology, 25 as a nurse practitioner. Dr. Hopkins is currently the director for research and evidence-based practice at the Montefiore Medical Center in Bronx, New York, where she is responsible for the oversight and management of nurse engagement in programs of research and evidence-based practice, academic and affiliations, nursing internet and intranet development, and presentations and publications for the department of nursing. This includes the management of selected staff and operations, academic affiliations and funded educational projects, survey preparation, specialized training initiatives, education related to promotion of nursing research and evidence-based practice, oversight of project management, and funding attainment. 

Dr. Hopkins has received numerous awards for her accomplishments in clinical and research work and since 1927, has published over 20 articles in various medical journals. She holds bachelor’s and master’s degrees in Nursing Science from the College of New Rochelle where she also studied to become a family nurse practitioner. She received her doctorate from Pace University in New York City. Dr. Hopkins serves on the Advisory Committee for the ACCC Institute for Clinical Immuno-Oncology.

Mark Liu is the Director of Strategic Initiatives for the oncology service line at the Mount Sinai Health System—an eight-hospital integrated health system in all five boroughs of New York City. He works closely with senior leadership to develop long-term strategy, while collaborating to drive critical projects to completion.

He first joined Mount Sinai as part of a team to facilitate the build of Mount Sinai Health Partners, a new entity advancing population health within the health system. Prior to this, Liu managed ambulatory care operations at Memorial Sloan Kettering Cancer Center across nine different solid and hematologic cancers during his eight-year tenure.

He received a Bachelor of Science, double majoring in Integrated Neuroscience and Sociology, from Binghamton University.  Liu was selected as a 2008 fellow for the New York University (NYU) Leadership Initiative and NYU Wagner Fellowship for Emerging Leaders in Public Service. He is currently completing his Master of Healthcare Administration at the Mailman School of Public Health at Columbia University.

Daniel Mulkerin, MD, graduated from Jefferson Medical College. He then completed his residency in internal medicine and fellowship in medical oncology at the University of Wisconsin Hospital and Clinics. Dr. Mulkerin joined the UW Medical School faculty in 1999 and is currently an assistant professor in the department of medicine, section of medical oncology. His clinical expertise is in the treatment of gastrointestinal malignancies, including liver and pancreas, esophageal, stomach, biliary, colon, rectal, and anal cancers. He is actively involved in the development of new therapies for patients with these diseases. Dr. Mulkerin also serves as regional director of the University of Wisconsin Carbone Cancer Center regional cancer center network, which includes affiliate sites in eight communities within Wisconsin and Illinois.

Ruth O’Regan, MD, is the Chair of Medicine and Charles A. Dewey Professor at the University of Rochester. She also serves as Physician-in-Chief of Strong Memorial Hospital and as Associate Director of Education and Mentoring at the Wilmot Cancer Institute at University of Rochester. Her focus is on breast cancer, resistant breast cancers, early drug development, research identifying mechanisms of resistance to breast-cancer therapies, and research development of new therapies with a specific focus on triple negative breast cancer.

She previously served as Division Chief of Hematology, Medical Oncology and Palliative Care in the Department of Medicine, and as Deputy Director at the Carbone Cancer Center at the University of Wisconsin School of Medicine and Public Health (UWSMPH). She served as Chief Scientific officer of the Big Ten Cancer Research Consortium, and Vice-Chair of the National Comprehensive Cancer Network’s Board of Directors.

Dr. O’Regan earned her Medical Degree from University College in Dublin, Ireland. She went on to complete her Internal Medicine residency at the Medical College of Wisconsin, and her Hematology/Oncology fellowship at Northwestern University.